Protein malfolding plays an important role neurodegenerative conditions, such as Parkinson's Disease, Alzheimer's Disease and Motor Neuron Disease. Accumulating evidence suggests that environmental agents may contribute to the pathophysiology of these common disorders by perturbing protein folding, either directly or indirectly through their effects on cell metabolism. However, little is known about how cells adapt to the threat of environmentally-induced proteotoxicity. This study will exploit arsenic as a model for an environmental toxin that adversely affects protein folding and one that represents an important public health hazard affecting multiple organ systems. Two recently-identified adaptations to arsenic exposure will serve as this study's point of departure: (1) Regulated attenuation of new protein synthesis. (2) Modification of the cell's protein degradation apparatus to better accommodate it to arsenic-induced proteotoxicity. Stress-induced phosphorylation of translation initiation factor 2a (elF2a) attenuates protein synthesis and activates a salubrious gene expression program known as the Integrated Stress Response (ISR), which reduces the stress caused by arsenic-induced protein malfolding. Therefore, elF2a phosphorylation has emerged as an important component of cellular unfolded protein responses (UPR). Phosphatases that dephosphorylate elF2a will be characterized in an effort to identify specific biochemical steps whose inhibition activates the ISR. The physiological significance of inhibiting elF2a phosphatases will be tested in mouse models of neurodegenerative diseases. These studies will uncover the promise and potential limitations of therapeutic strategies to protect against proteotoxicity by inhibiting elF2a phosphatases. AIRAP, a novel arsenite induced protein, adapts the proteasome's regulatory cap to the conditions in cells experiencing arsenite-induced proteotoxicity and thereby promotes the cell's ability to deal with malfolded proteins. In an effort to understand how the intracellular protein degradation machinery adapts to proteotoxicity, arsenite-induced and AIRAP-dependent changes in the composition of the proteasome will be characterized by proteomic approaches. Gene knock out experiments in mouse and worms will be used to create experimental systems lacking AIRAP, and these will be applied as tools to identify arsenite-modified proteins whose degradation depends on AIRAP induction and AIRAP integration into the 19S proteasome regulatory particle. In vitro biochemical assays of purified proteasomes containing AIRAP will be used to characterize functionally proteasomal adaptation to environmentally-induced protein malfolding. The goal of this research program is to reduce the cellular adaptations to protein malfolding induced by environmental toxins to their molecular constituents. This will lay the groundwork for identifying relevant bio- markers of exposure and for future preventive and therapeutic interventions against neurodegeneration. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
2R01ES008681-11
Application #
7090484
Study Section
Neurotoxicology and Alcohol Study Section (NAL)
Program Officer
Balshaw, David M
Project Start
1996-09-30
Project End
2011-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
11
Fiscal Year
2006
Total Cost
$401,375
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Levin, Richard I; Fishman, Glenn I (2011) The power of Pasteur's quadrant: cardiovascular disease at the turn of the century. FASEB J 25:1788-92
Chin, King-Tung; Kang, Guoxin; Qu, Jiaxiang et al. (2011) The sarcoplasmic reticulum luminal thiol oxidase ERO1 regulates cardiomyocyte excitation-coupled calcium release and response to hemodynamic load. FASEB J 25:2583-91
Wiseman, R Luke; Zhang, Yuhong; Lee, Kenneth P K et al. (2010) Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1. Mol Cell 38:291-304
Blais, Jaime D; Chin, King-Tung; Zito, Ester et al. (2010) A small molecule inhibitor of endoplasmic reticulum oxidation 1 (ERO1) with selectively reversible thiol reactivity. J Biol Chem 285:20993-1003
Masciarelli, Silvia; Fra, Anna M; Pengo, Niccolò et al. (2010) CHOP-independent apoptosis and pathway-selective induction of the UPR in developing plasma cells. Mol Immunol 47:1356-65
Tao, Jiahui; Petrova, Kseniya; Ron, David et al. (2010) Crystal structure of P58(IPK) TPR fragment reveals the mechanism for its molecular chaperone activity in UPR. J Mol Biol 397:1307-15
Zito, Ester; Melo, Eduardo Pinho; Yang, Yun et al. (2010) Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin. Mol Cell 40:787-97
Zito, Ester; Chin, King-Tung; Blais, Jaime et al. (2010) ERO1-beta, a pancreas-specific disulfide oxidase, promotes insulin biogenesis and glucose homeostasis. J Cell Biol 188:821-32
Ye, Jiangbin; Kumanova, Monika; Hart, Lori S et al. (2010) The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J 29:2082-96
Haynes, Cole M; Yang, Yun; Blais, Steven P et al. (2010) The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol Cell 37:529-40

Showing the most recent 10 out of 80 publications